IRCT20200929048884N1 IRCT 2020-10-05 Ghoum University of Medical Sciences Clarithromycin Based and Levofloxacin Based Quadruple Therapy in Helicobacter Pylori Eradication Effectiveness of Clarithromycin Based and Levofloxacin Based Quadruple Therapy in Combination with Atorvastatin for Helicobacter Pylori Eradication 2020-10-11 anticipated 200 Complete https://irct.ir/trial/51385 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be assigned to 2 groups of interventions by block randomization. For this purpose blocks of size 4 will be used. 50 blocks will include. To hide the random allocation, the numbered dark envelopes will be used, in which the group name is specified in the random sequence generated. Then, according to the order of entering samples, for the first patient the envelope number one is opened and the group will be identified until the end. 3 Helicobacter pylori infection. Intervention 1: Intervention group: Pentoprazole 40 tablet, Octover company, orally, twice a day + Atorvastatin 40 tablet, orally, once a day + Bismuth 500 tablet, orally, four times a day + Amoxicillin 1 g capsule , orally, twice a day + Clarithromycin 500 tablet (Ferromilide, Octover company), orally, twice a day, for 14 days. Intervention 2: Control group: Pentoprazole 40 tablet, Octover company, orally, twice a day + Atorvastatin 40 tablet, orally, once a day + Bismuth 500 tablet, orally, four times a day + Amoxicillin 1 g capsule , orally, twice a day + Levofloxacin 500 tablet, Abidi company, orally, once daily for 14 days. No - There is not a plan to make this available Justification or reason for not sharing IPD is The data are specific to this study